These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9841701)

  • 1. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy.
    Ruchelli E; Wenner W; Voytek T; Brown K; Liacouras C
    Pediatr Dev Pathol; 1999; 2(1):15-8. PubMed ID: 9841701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.
    Liacouras CA; Wenner WJ; Brown K; Ruchelli E
    J Pediatr Gastroenterol Nutr; 1998 Apr; 26(4):380-5. PubMed ID: 9552132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic infiltration of the esophagus: gastroesophageal reflux versus eosinophilic esophagitis in children--discussion on daily practice.
    Cury EK; Schraibman V; Faintuch S
    J Pediatr Surg; 2004 Feb; 39(2):e4-7. PubMed ID: 14966764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of five maintenance therapies for reflux esophagitis.
    Vigneri S; Termini R; Leandro G; Badalamenti S; Pantalena M; Savarino V; Di Mario F; Battaglia G; Mela GS; Pilotto A
    N Engl J Med; 1995 Oct; 333(17):1106-10. PubMed ID: 7565948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
    Dunbar KB; Agoston AT; Odze RD; Huo X; Pham TH; Cipher DJ; Castell DO; Genta RM; Souza RF; Spechler SJ
    JAMA; 2016 May; 315(19):2104-12. PubMed ID: 27187303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of omeprazole on mechanisms of gastroesophageal reflux in childhood.
    Cucchiara S; Minella R; Campanozzi A; Salvia G; Borrelli O; Ciccimarra E; Emiliano M
    Dig Dis Sci; 1997 Feb; 42(2):293-9. PubMed ID: 9052509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis.
    Chehade M; Sampson HA; Morotti RA; Magid MS
    J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):319-28. PubMed ID: 17873744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease.
    Schenk BE; Kuipers EJ; Klinkenberg-Knol EC; Eskes SA; Meuwissen SG
    Am J Gastroenterol; 1999 Apr; 94(4):884-7. PubMed ID: 10201451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
    Baron TH; Richter JE; Singh S; Tennyson GS; Andres JM
    Am J Gastroenterol; 1993 Feb; 88(2):289-92. PubMed ID: 8424436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
    Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
    Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of ranitidine in the treatment of gastroesophageal reflux and its complications].
    Mainguet P
    Rev Med Suisse Romande; 1995 Oct; 115(10):781-8. PubMed ID: 7501930
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis.
    Brodzicki J; Trawińska-Bartnicka M; Korzon M
    Med Sci Monit; 2002 Jul; 8(7):CR529-37. PubMed ID: 12118204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
    Pace F; Sangaletti O; Zhu H; Bianchi Porro G
    Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The medical therapy of reflux oesophagitis.
    Tytgat GN; Nio CY
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of esophageal manometry and gastroesophageal pH monitoring for responsiveness of reflux disease to medical therapy in children.
    Cucchiara S; Campanozzi A; Greco L; Franco MT; Emiliano M; Alfieri E; Calabrese F; Numeroso V
    Am J Gastroenterol; 1996 Apr; 91(4):680-5. PubMed ID: 8677928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked eosinophilia in esophageal mucosal biopsies.
    Lee RG
    Am J Surg Pathol; 1985 Jul; 9(7):475-9. PubMed ID: 4091182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.